# Faeth Therapeutics, Inc.: Form 8-K, filed Mar 13, 2023

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: 8-K
- Filed: 2023-03-13
- Accepted by EDGAR: Mar 13, 2023, 07:31 ET
- Period: 2023-03-13
- Accession: 0001193125-23-068480
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312523068480/d467513d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312523068480/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312523068480/d467513d8k.htm

Filed Mar 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-068480. Last ingested by Listed: Nov 9, 2026, 18:03 ET. No prices; not investment advice.